Abstract
Introduction
In 2013, 2.7 million adults over the age of 17 were diagnosed with diabetes in the UK. [1] 10% had type I diabetes [2] and 90% had type II diabetes, which is more likely to be influenced by lifestyle factors.
[3] Type II diabetes is socially patterned, with prevalence approximately 50% higher in the most deprived compared with the least deprived quintile group. [4] Both types of diabetes have potentially serious complications decreasing both quality and length of life.
[3] The NHS in England spent £3.9 million on diabetes services in 2009-10, approximately 4% of the NHS budget. [5] One important aspect of diabetes management is the control of HbA1c (glycated haemoglobin) levels, which reduces the risk of complications, hospitalisation and mortality. [6] In 2003, the UK Government made reducing health inequality a key priority of national health policy. [7, 8] This was supported by several major investments with potential impact on reducing inequalities. Firstly, the Quality and Outcomes Framework (QOF) pay-for-performance programme introduced in 2004.
[9] The QOF contains financial incentives for achieving clinical targets in controlling glycaemia, cholesterol levels, and blood pressure; and also for the recording of retinal screening, foot examination, neuropathy testing, and urine examination for microalbuminuria. [12] In 2012, the NHS Health and Social Care Act gave the NHS an explicit duty to consider reducing inequalities in healthcare outcomes. [13] In this study we examine NHS equity performance in tackling inequalities in diabetes outcomes during this key period.
Methods
We identified three indicators to track socioeconomic inequality in the outcomes of care for diabetes along the patient pathway. These indicators were developed using an iterative process involving the public, public health experts and NHS experts including those from primary and secondary care. [8] The first indicator was the achievement of good glycaemic control in patients with diabetes using the lower threshold target for HbA1c from QOF. We compared the number of people achieving this threshold with the number of people registered as having diabetes at GP practice level. The threshold has changed on various occasions since the inception of QOF in 2004/5 as detailed in Table   1 and we used the relevant threshold for each period.
The second indicator was preventable emergency hospitalisation for diabetes. We counted the number of people per 100,000 population having one or more emergency hospitalisations for those diabetes complications that are defined as being preventable by the NHS outcomes framework. [14] The ICD-codes for these complications are listed in Table 2 .
The final indicator was amenable mortality from diabetes related causes. This was defined as the number of deaths in a given year per 100,000 population under the age of 75 from diabetes related causes considered amenable to health care by the ONS (primary cause of death ICD-10 codes E10 to E14). [15] For glycaemic control, we started with QOF achievement data which was available at GP practicelevel. We then used the 'NHS Attribution Data Set' of GP-registered populations to attribute glycaemic control data from practice to neighbourhood level using lower layer super output areas (LSOAs). Where LSOAs were attributed to more than one practice a population weighted average of glycaemic control scores from the relevant practices were used, assuming that the same level of glycaemic control was achieved across all practice patients independent of their LSOA of residence. For the emergency hospitalisation outcome we used the Hospital Episodes Statistics (HES) dataset provided by the Health and Social Care Information Centre (HSCIC). For the amenable mortality outcome we used the Office of National Statistics (ONS) mortality dataset. These outcomes are available at LSOA-level and were indirectly standardised for age and sex at small area level.
We measured absolute and relative inequality in these indicators using the slope index of inequality (SII) and relative index of inequality (RII) respectively. The SII was computed for each year by estimating an ordinary least squares regression of the LSOA level indicator value against the LSOA level deprivation fractional rank (measured on a 0-1 scale where 0 is the least deprived neighbourhood and 1 is the most deprived). The RII was calculated by expressing the SII as a proportion of the national mean level of the indicator. The SII can be interpreted as the modelled difference in event count between the least deprived and most deprived LSOAs in the country, taking into account the distribution of event counts across the deprivation range. The RII can be interpreted as the proportional gap between the most and least deprived areas. For emergency hospitalisation and amenable mortality, where "more is worse", a positive association implies "prorich" inequality whilst a negative association implies "pro-poor" inequality. To ease comparison with the glycaemic control indicator, where "more is better", we multiplied the SII by minus one, so that a positive sign also indicates "pro-rich" inequality. The area under the SII line was used to estimate the excess number of people experiencing the outcome measured by the indicator associated with socio-economic inequality -the "real inequality gap". The assumption being that the level of the outcome observed in the least deprived area was the optimal level of the outcome and anything above this level for bad outcomes and below this level for good outcomes represented the excess associated with socio-economic inequality.
Linear regression models were computed using pooled data for the first and last years, including interaction terms between year and deprivation, to determine the magnitude and statistical significance of changes in inequality between the beginning and end of the analysis period. All statistical analysis was carried out using R (version 3.2.3). 
Results

In
Glycaemic control (table 3)
In 2004/5 mean glycaemic control performance in England was 58.64% (95% CI 58.63 to 68.64). The SII was 3.76 (95% CI 3.40 to 4.11) indicating that the most deprived patients are nearly four percentage points less likely to achieve good glycaemic control than the least deprived patients.
Between 2004/5 to 2011/12 there was an improvement in mean glycaemic control performance of 3.72 percentage points (95% CI 3.72 to 3.72). However, inequality in glycaemic control was unchanged over the period according to both absolute and relative indices of inequality (SII difference 0.04, 95% CI -0.43 to 0.52). There was an improvement in primary care quality in between 2010/11 and 2011/12 which may be the result of change in the HbA1C target from <7 to <7.5 that year. This also may have reduced hospitalisation (especially hypoglycaemia) due to less intensive treatment.
Emergency hospitalisation (Table 3 and 
Diabetes mortality (Table 3 and appendix 2)
In 2004/5 the mean rate of mortality from diabetes-related causes was 3.62 (95% CI 3.57 to 3.67) deaths per 100,000 population. The SII was 5.10 (95% CI 4.49 to 5.71) and socioeconomic inequality was associated with an excess of 1,176 (95% CI 1,036 to 1,306) deaths. The most common causes of mortality were unspecified diabetes without complications, and unspecified diabetes mellitus with peripheral circulatory complications.
Between 2004/5 and 2011/12 average mortality fell by 1.57 (95% CI 1.49 to 1.65) deaths per 100,000 population. Inequality in diabetes mortality as measured by the SII also improved, falling by 2.68 (95% CI 1.93 to 3.43) resulting in 594 (95% CI 420 to 767) fewer deaths. The main sub-categories of mortality reduction were unspecified diabetes without complications which fell from 810 to 320 deaths, and unspecified diabetes mellitus with peripheral circulatory complications which fell from 257 to 139 deaths. In contrast, there was a rise in deaths in unspecified diabetes with ketoacidosis from 84 to 155 deaths.
Discussion
Summary
This is the first study to examine how the NHS performed in reducing socioeconomic inequalities in diabetes outcomes from 2004/5 to 2011/12. During this period, healthcare outcomes improved in all social groups for glycaemic control and mortality from diabetes, with larger and faster mortality reductions in more deprived social groups. By contrast, both average outcomes and inequalities deteriorated in relation to preventable emergency hospitalisation for diabetes-related complications. The fall in diabetes-related mortality is a remarkable achievement, given that diabetes prevalence is rising and the targeting of NHS resources often does not promote health equity. [16] This finding is consistent with other UK literature and a sign of NHS success with improving the quality of healthcare for diabetes, and more importantly improving the quality of healthcare for coronary heart disease and other co-morbidities which contribute to diabetic mortality. [17] Falling mortality may be partly due to the increase in prescribing of statins in diabetes patients and more aggressive control of blood pressure, lipid levels and hyperglycaemia, which has been shown to reduce morbidity and mortality. [18] By contrast, the growth in emergency admissions for diabetes is worrying. It is partly explained by better disease detection by the recent addition of the HbA1c test to diagnose diabetes, and increasing prevalence of diabetes rising from 
Strengths and limitations
This study used ten years of data including outcome data on virtually all individuals with diabetes in [25] These differences may be explained by the fact that Calderón-Larrañaga adjusted the rate of preventable hospitalisation for the prevalence of diabetes, whereas Dusheiko adjusted the rate of preventable hospitalisation by population count, age and sex alone as we have done in our analysis. Both approaches have their merits, since although diabetes is becoming more common the increase in prevalence may be overestimated due to better case finding. [19] Our findings of an increase in the proportion of patients meeting targets for HbA1c are similar to findings in Australia, however contrast with findings in the USA where no significant change occurred between 2007 and 2012. [26, 27] Our findings of a fall in mortality for diabetes are similar to the USA, but contrast with findings in Australia where mortality rates have been unchanged from 1997 to 2012. [27, 28] Our findings of increased admissions are similar to both Australia and the USA. [27, 29] The increasing admissions for diabetic ketoacidosis in type 2 diabetes may be a side effect of newer diabetic drugs. [30] Implications for research and practice
The causes of the increase in preventable admissions for hypoglycaemia and ketoacidosis in both type I and type II diabetes and increasing inequalities need further research. [31] Reducing inequalities in diabetes is likely to require complex interventions to improve the coordination of care between multiple providers of care both within and outside the healthcare system. GPs need to be aware of socioeconomic inequalities in diabetes care. NICE should review the current target HbA1C Data derived from patient numbers between 1 and 4 are omitted for confidentiality purposes, and displayed as *
